G
GLP1 Lawsuit
Mass Tort Case Review
Call
GLP-1 Drug Injury

Trulicity Lawsuit

Trulicity is Eli Lilly's dulaglutide injection for type 2 diabetes. As a GLP-1 receptor agonist it carries the same class risks driving the broader GLP-1 mass tort.

Call (717) 724-7503

Free Confidential Case Review

No fee unless you win. Takes under 60 seconds.

Trulicity in the GLP-1 litigation

Trulicity is a once-weekly GLP-1 receptor agonist with a long history of use in diabetes care. Plaintiffs allege that the original warnings on Trulicity did not adequately describe the risk of gastroparesis, ileus, or chronic gallbladder injury.

Qualifying injuries

Documented Trulicity use plus hospitalization or formal diagnosis of a qualifying injury — gastroparesis, severe pancreatitis, intestinal obstruction, ileus, gallbladder disease, vision loss — supports a claim.

Frequently Asked Questions

Get your free, confidential case review

Takes under 60 seconds. No fee unless you win.

Free Confidential Case Review

No fee unless you win. Takes under 60 seconds.